Board Regulations Board Regulation No. 8, S.2025
DDB
Dangerous Drugs Board
Administrative issuances
22 issuances
Board Regulations Board Regulations No. 7, S.2025
Inclusion of P-2-P Methyl Glycidic Acid and Eight of its Esters (Methyl Ester, Ethyl Ester, Propyl Ester, Isopropyl Ester, Butyl Ester, Isobutyl Ester, Sec-Butyl Ester and Tert-Butyl Ester) in the List of Dangerous Drugs
Board Regulations Board Regulation No. 6, S.2025
Inclusion of 4-Piperidone and 1-BOC-Piperidone in the List of Dangerous Drugs
Board Regulations Board Regulations No. 5, S.2025
Inclusion of Bromozolam in the List of Dangerous Drugs
Board Regulations Board Regulation No. 4, S.2025
Inclusion of 2-Fluorodeschloroketamine in the List of Dangerous Drugs
Board Regulations Board Regulations No. 3, S.2025
Inclusion of Dipentylone in the List of of Dangerous Drugs
Board Regulations Board Regulations No. 2, S.2025
Inclusion of 3-Chloromethcathinone (3-CMC) in the List of Dangerous Drugs
Board Regulations Board Regulation No. 1, S.2025
Inclusion of Butonitazene in the List of Dangerous Drugs
Board Regulations Board Regulation No. 3 S. of 2024
Mandatory Registration of Private and/or Government Entities Providing Narcotics Detection Dog Services and Accreditation of Narcotics Detection Dogs
Regulations Board Regulation No. 2, S.2024
Extension of the Provisional Removal of Lianhua Qingwen from the List of Dangerous Drugs for Another Period of One (1) Year
Board Regulations Board Regulation No. 1, S.2024
Creating a Technical Working Group for the Executive Review of Republic Act No. 9165 or the Comprehensive Dangerous Drugs Act of 2002
Board Regulations Board Regulation No. 6 Series of 2023